<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04180410</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02986-51</org_study_id>
    <nct_id>NCT04180410</nct_id>
  </id_info>
  <brief_title>Monitoring of Regional Lung Ventilation by Chest Electrical Impedance in the Course of Extubation</brief_title>
  <acronym>EXIT</acronym>
  <official_title>Monitoring of Regional Lung Ventilation by Chest Electrical Impedance in the Course of Extubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioSerenity</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BioSerenity</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Electrical Impedance Tomography (EIT) is a non-invasive exam. This exam performed on the&#xD;
      lung continuously produces cross-sectional images of lung function. It may be relevant in&#xD;
      lung description.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim is to follow the patients after extubation for the lung description.&#xD;
&#xD;
      EIT exam is performed before extubation, during follow-up visits and 48H after extubation&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2020</start_date>
  <completion_date type="Anticipated">August 19, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 19, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>No-randomized,no-comparative study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>acute respiratory failure</measure>
    <time_frame>48 hours</time_frame>
    <description>Occurrence of extubation failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pulmonary ventilation</measure>
    <time_frame>48 hours</time_frame>
    <description>lung pulmonary volume (cm)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Respiratory Disease</condition>
  <arm_group>
    <arm_group_label>EIT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Electrical Impedance Tomography is performed before extubation, during follow up visits of extubation and 48H after extubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EIT</intervention_name>
    <description>Electrical Impedance Tomography is performed before extubation, during follow-up visits of extubation and 48H after extubation. Follow-up visits are shortened in case of extubation failure.</description>
    <arm_group_label>EIT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age&gt; 65 years&#xD;
&#xD;
          2. Invasive mechanical ventilation time greater than 48 hours&#xD;
&#xD;
          3. known or suspected Chronic obstructive pulmonary disease&#xD;
&#xD;
          4. Known or suspected heart failure&#xD;
&#xD;
          5. Success in the spontaneous ventilation and extubation test scheduled by the doctor in&#xD;
             charge&#xD;
&#xD;
          6. Patient or trusted person who has been informed of the study and has consented to&#xD;
             participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant women, minor patients&#xD;
&#xD;
          2. Patients under extracorporeal circulatory assistance (ECMO)&#xD;
&#xD;
          3. Refusal of the patient&#xD;
&#xD;
          4. Contraindications to the realization of the phrenic nerve stimulation technique:&#xD;
&#xD;
               -  Pacemaker, implantable cardiac defibrillator and other pacemakers&#xD;
&#xD;
               -  Spinal implants, thoracic drains ...&#xD;
&#xD;
               -  Copper allergy&#xD;
&#xD;
               -  Epileptic patients&#xD;
&#xD;
          5. Patients performing uncontrolled body movements&#xD;
&#xD;
          6. Contraindications to the realization of the technique of Electrical Imaging&#xD;
             Tomography:&#xD;
&#xD;
               -  Breast circumference not between 70 cm and 150 cm.&#xD;
&#xD;
               -  Body mass index (BMI) greater than 50&#xD;
&#xD;
               -  Impossibility of placing the CT belt at the level of the chest skin (lesions,&#xD;
                  bandages, dressings, chest drains ...)&#xD;
&#xD;
               -  Patients with unstable spinal lesions or fractures&#xD;
&#xD;
               -  Allergy to tomography belt materials: silicone, brass, stainless steel&#xD;
&#xD;
               -  Pacemaker, implantable cardiac defibrillator and other pacemakers&#xD;
&#xD;
          7. Patients under legal protection (tutorship / guardianship)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eleonore CAILLET</last_name>
    <phone>0156092017</phone>
    <email>eleonore.caillet@bioserenity.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aphp_La Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MARTIN DRES, DR</last_name>
    </contact>
    <investigator>
      <last_name>MARTIN DRES, DR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 24, 2019</study_first_submitted>
  <study_first_submitted_qc>November 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2019</study_first_posted>
  <last_update_submitted>December 18, 2020</last_update_submitted>
  <last_update_submitted_qc>December 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

